White paper on designing a risk evaluation and mitigation strategies (REMS) system to optimize the balance of patient access, medication safety, and impact on the health care system
Authors:
- Judy Crespi LoftonJLJudy Crespi Lofton
- Marcie BoughMBMarcie Bough
- 1 November 2009
- journal article
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 49 (6) , 729-743
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Risk management of drug products and the U.S. Food and Drug Administration: Evolution and contextDrug and Alcohol Dependence, 2009
- Drug-risk communication to pharmacists: Assessing the impact of risk-minimization strategies on the practice of pharmacyJournal of the American Pharmacists Association, 2008
- What Is the Best Approach to Reducing Birth Defects Associated with Isotretinoin?PLOS Medicine, 2006
- ThalidomideThe Lancet, 2004
- The Risk Revolution: An Examination of the Regulatory EnvironmentJournal of the American Pharmaceutical Association, 2001
- Development of the Clozaril Patient Management SystemPsychopharmacology, 1989